Andreas WILMEN

Person

Cologne, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Epitope of optimized humanized monoclonal antibodies against activa...
- Patent number 11,077,187
- Issue date Aug 3, 2021
- Oklahoma Medical Research Foundation
- Xiao-Yan Zhao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies capable of binding to the coagulation factor XIa and use...
- Patent number 11,046,783
- Issue date Jun 29, 2021
- Bayer Pharma Aktiengesellschaft
- Andreas Wilmen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against factor XI and uses thereof
- Patent number 10,654,941
- Issue date May 19, 2020
- Bayer Pharma Aktiengesellschaft
- Andreas Wilmen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies capable of binding to the coagulation factor XIa and use...
- Patent number 10,221,247
- Issue date Mar 5, 2019
- Bayer Pharma Aktiengesellschaft
- Andreas Wilmen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids and host cells expressing antibodies capable of bindi...
- Patent number 10,040,866
- Issue date Aug 7, 2018
- Bayer Pharma Aktiengesellschaft
- Andreas Wilmen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies capable of binding to the coagulation Factor XI and/or i...
- Patent number 9,783,614
- Issue date Oct 10, 2017
- Bayer Pharma Aktiengesellschaft
- Andreas Wilmen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
- Patent number 9,777,063
- Issue date Oct 3, 2017
- Bayer Intellectual Property GmbH
- Christoph Freiberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralizing prolactin receptor antibodies and their therapeutic use
- Patent number 9,649,374
- Issue date May 16, 2017
- Bayer Intellectual Property GmbH
- Christiane Otto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazo-, pyrazolopyrazines and imidazotriazines and their use
- Patent number 9,434,731
- Issue date Sep 6, 2016
- Bayer Intellectual Property GmbH
- Stephan Siegel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Relaxin fusion polypeptides and uses thereof
- Patent number 9,382,305
- Issue date Jul 5, 2016
- Bayer Intellectual Property GmbH
- Andreas Wilmen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
- Patent number 9,353,186
- Issue date May 31, 2016
- Bayer Intellectual Property GmbH
- Christoph Freiberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Neutralizing prolactin receptor antibodies and their therapeutic use
- Patent number 9,241,989
- Issue date Jan 26, 2016
- Bayer Intellectual Property GmbH
- Christiane Otto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted imidazopyrimidines and triazolopyrimidines
- Patent number 9,051,323
- Issue date Jun 9, 2015
- Bayer Intellectual Property GmbH
- Stephan Siegel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyridines, and use thereof as GSK3 inhibitors
- Patent number 8,664,246
- Issue date Mar 4, 2014
- Bayer Intellectual Property GmbH
- Stephan Siegel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo-, pyrazolopyrazines and imidazotriazines and their use
- Patent number 8,476,267
- Issue date Jul 2, 2013
- Bayer Intellectual Property GmbH
- Stephan Siegel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolo...
- Patent number 8,436,003
- Issue date May 7, 2013
- Bayer Intellectual Property GmbH
- Stephan Siegel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazopyrimidines and triazolopyrimidines
- Patent number 8,273,752
- Issue date Sep 25, 2012
- Bayer Intellectual Property GmbH
- Stephan Siegel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
NOVEL ANTI-A2AP ANTIBODIES AND USES THEREOF
- Publication number 20240166766
- Publication date May 23, 2024
- Bayer Aktiengesellschaft
- Stefan HEITMEIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL ANTI-A2AP ANTIBODIES AND USES THEREOF
- Publication number 20240010750
- Publication date Jan 11, 2024
- Bayer Aktiengesellschaft
- Stefan HEITMEIER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
REVERSAL AGENTS FOR NEUTRALIZING THE THERAPEUTIC ACTIVITY OF ANTI-F...
- Publication number 20210395390
- Publication date Dec 23, 2021
- Bayer Aktiengesellschaft
- Andreas WILMEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRAIN NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES
- Publication number 20210147504
- Publication date May 20, 2021
- Bayer Aktiengesellschaft
- Damian BROCKSCHNIEDER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ATRIAL NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES
- Publication number 20210139555
- Publication date May 13, 2021
- Bayer Aktiengesellschaft
- Anke MAYER-BARTSCHMID
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
C-TYPE NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES
- Publication number 20210079056
- Publication date Mar 18, 2021
- Bayer Aktiengesellschaft
- Damian BROCKSCHNIEDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES CAPABLE OF BINDING TO THE COAGULATION FACTOR XIA AND USE...
- Publication number 20190284300
- Publication date Sep 19, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Andreas WILMEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL ANTIBODIES AGAINST FACTOR XI AND USES THEREOF
- Publication number 20190225705
- Publication date Jul 25, 2019
- BAYER PHARMA AKTIENGESELLSCHAFT
- Andreas WILMEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EPITOPE OF OPTIMIZED HUMANIZED MONOCLONAL ANTIBODIES AGAINST ACTIVA...
- Publication number 20180326053
- Publication date Nov 15, 2018
- Bayer HealthCare, LLC
- Xiao-Yan ZHAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES CAPABLE OF BINDING TO THE COAGULATION FACTOR XIA AND USE...
- Publication number 20180112009
- Publication date Apr 26, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Andreas WILMEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACIDS AND HOST CELLS EXPRESSING ANTIBODIES CAPABLE OF BINDI...
- Publication number 20180051093
- Publication date Feb 22, 2018
- BAYER PHARMA AKTIENGESELLSCHAFT
- Andreas WILMEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZING PROLACTIN RECEPTOR ANTIBODY MAT3 AND ITS THERAPEUTIC USE
- Publication number 20160319029
- Publication date Nov 3, 2016
- Bayer Intellectual Property GmbH
- Christoph Freiberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PDGFRBETA-FC FUSION PROTEINS AND USES THEREOF
- Publication number 20160009776
- Publication date Jan 14, 2016
- BAYER PHARMA AKTIENGESELLSCHAFT
- Lars Linden
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSION POLYPEPTIDES AND USES THEREOF
- Publication number 20150329613
- Publication date Nov 19, 2015
- BAYER PHARMA AKTIENGESELLSCHAFT
- Andreas WILMEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C (aPC)
- Publication number 20150307625
- Publication date Oct 29, 2015
- Bayer HealthCare LLC
- Xiao-Yan ZHAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies capable of binding to the coagulation Factor XI and/or i...
- Publication number 20150099298
- Publication date Apr 9, 2015
- Andreas Wilmen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RELAXIN FUSION POLYPEPTIDES AND USES THEREOF
- Publication number 20140187491
- Publication date Jul 3, 2014
- Bayer Intellectual Property GmbH
- Andreas Wilmen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS RELEASING RELAXIN AND USES THEREOF
- Publication number 20140148390
- Publication date May 29, 2014
- Bayer Intellectual Property GmbH
- Ulrich Haupts
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUTRALIZING PROLACTIN RECEPTOR ANTIBODY MAT3 AND ITS THERAPEUTIC USE
- Publication number 20140141003
- Publication date May 22, 2014
- Bayer Intellectual Property GmbH
- Christoph Freiberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED IMIDAZO- AND TRIAZOLOPYRIMIDINES, IMIDAZO- AND PYRAZOLO...
- Publication number 20130296343
- Publication date Nov 7, 2013
- Stephan SIEGEL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE
- Publication number 20130272968
- Publication date Oct 17, 2013
- Bayer Intellectual Property GmbH
- Christiane Otto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZO-, PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AND THEIR USE
- Publication number 20130261115
- Publication date Oct 3, 2013
- Stephan SIEGEL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE
- Publication number 20130129739
- Publication date May 23, 2013
- Bayer Intellectual Property GmbH
- Christiane Ottto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES
- Publication number 20130040946
- Publication date Feb 14, 2013
- Bayer Intellectual Property GmbH
- Stephan Siegel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE
- Publication number 20120321632
- Publication date Dec 20, 2012
- Bayer Intellectual Property GmbH
- Christiane Otto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted pyridines, and use thereof as Gsk3 inhibitors
- Publication number 20110190316
- Publication date Aug 4, 2011
- Bayer Schering Pharma Aktiengesellschaft
- Stephan Siegel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED IMIDAZO- AND TRIAZOLOPYRIMIDINES, IMIDAZO- AND PYRAZOLO...
- Publication number 20110144131
- Publication date Jun 16, 2011
- BAYER SCHERING PHARMA AKTIENGESELLESCHAFT
- Stephan Siegel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES
- Publication number 20100113441
- Publication date May 6, 2010
- Bayer Schering Pharma Aktiengesellschaft
- Stephan Siegel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITION OF PDE2A
- Publication number 20100035882
- Publication date Feb 11, 2010
- Peter Ellinghaus
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THEIR USE
- Publication number 20090258877
- Publication date Oct 15, 2009
- Bayer Healthcare AG
- Stephan Siegel
- C07 - ORGANIC CHEMISTRY

Andreas WILMEN

Person

Patents Grantslast 30 patents

Epitope of optimized humanized monoclonal antibodies against activa...

Antibodies capable of binding to the coagulation factor XIa and use...

Antibodies against factor XI and uses thereof

Antibodies capable of binding to the coagulation factor XIa and use...

Nucleic acids and host cells expressing antibodies capable of bindi...

Antibodies capable of binding to the coagulation Factor XI and/or i...

Neutralizing prolactin receptor antibody Mat3 and its therapeutic use

Neutralizing prolactin receptor antibodies and their therapeutic use

Imidazo-, pyrazolopyrazines and imidazotriazines and their use

Relaxin fusion polypeptides and uses thereof

Neutralizing prolactin receptor antibody Mat3 and its therapeutic use

Neutralizing prolactin receptor antibodies and their therapeutic use

Substituted imidazopyrimidines and triazolopyrimidines

Substituted pyridines, and use thereof as GSK3 inhibitors

Imidazo-, pyrazolopyrazines and imidazotriazines and their use

Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolo...

Substituted imidazopyrimidines and triazolopyrimidines

Patents Applicationslast 30 patents

NOVEL ANTI-A2AP ANTIBODIES AND USES THEREOF

NOVEL ANTI-A2AP ANTIBODIES AND USES THEREOF

REVERSAL AGENTS FOR NEUTRALIZING THE THERAPEUTIC ACTIVITY OF ANTI-F...

BRAIN NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

ATRIAL NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

C-TYPE NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

ANTIBODIES CAPABLE OF BINDING TO THE COAGULATION FACTOR XIA AND USE...

NOVEL ANTIBODIES AGAINST FACTOR XI AND USES THEREOF

EPITOPE OF OPTIMIZED HUMANIZED MONOCLONAL ANTIBODIES AGAINST ACTIVA...

ANTIBODIES CAPABLE OF BINDING TO THE COAGULATION FACTOR XIA AND USE...

NUCLEIC ACIDS AND HOST CELLS EXPRESSING ANTIBODIES CAPABLE OF BINDI...

NEUTRALIZING PROLACTIN RECEPTOR ANTIBODY MAT3 AND ITS THERAPEUTIC USE

PDGFRBETA-FC FUSION PROTEINS AND USES THEREOF

FUSION POLYPEPTIDES AND USES THEREOF

MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C (aPC)

Antibodies capable of binding to the coagulation Factor XI and/or i...

RELAXIN FUSION POLYPEPTIDES AND USES THEREOF

FUSION PROTEINS RELEASING RELAXIN AND USES THEREOF

NEUTRALIZING PROLACTIN RECEPTOR ANTIBODY MAT3 AND ITS THERAPEUTIC USE

SUBSTITUTED IMIDAZO- AND TRIAZOLOPYRIMIDINES, IMIDAZO- AND PYRAZOLO...

NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE

IMIDAZO-, PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AND THEIR USE

NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE

SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES

NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE

Substituted pyridines, and use thereof as Gsk3 inhibitors

SUBSTITUTED IMIDAZO- AND TRIAZOLOPYRIMIDINES, IMIDAZO- AND PYRAZOLO...

SUBSTITUTED IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES

INHIBITION OF PDE2A

TRIAZOLOTRIAZINES AND TRIAZOLOPYRAZINES AND THEIR USE